Browse

Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer

DC Field Value Language
dc.contributor.authorNo, Jae Hong-
dc.contributor.authorJeon, Yong-Tark-
dc.contributor.authorPark, In-Ae-
dc.contributor.authorKim, Yong-Beom-
dc.contributor.authorKim, Jae Weon-
dc.contributor.authorPark, Noh-Hyun-
dc.contributor.authorKang, Soon-Beom-
dc.contributor.authorHan, Jae Yong-
dc.contributor.authorLim, Jeong Mook-
dc.contributor.authorSong, Yong-Sang-
dc.date.accessioned2017-01-31T06:14:33Z-
dc.date.available2017-01-31T06:14:33Z-
dc.date.issued2011-
dc.identifier.citationGynecologic Oncology, vol.121 no.1, pp. 8-12ko_KR
dc.identifier.issn0090-8258-
dc.identifier.urihttps://hdl.handle.net/10371/100301-
dc.description.abstractObjective. Activation of the mammalian target of rapamycin (mTOR) pathway enhances cell survival and growth by regulating the efficiency of protein translation. This study was conducted to evaluate the association of activated mTOR signaling molecules with the clinicopathologic characteristics in epithelial ovarian cancer.
Methods. Immunohistochemical staining with antibodies against p-4EBP1, p-mTOR, and p-p70S6K were performed on specimens of 103 patients with ovarian cancer. Tumors were classified as chemoresistant in cases where time to recurrence after the end of chemotherapy was shorter than 6 months.
Results. Expressions of p-mTOR, p-4EBP1, and p-p70S6K were detected in 47.6%, 85.4%, and 64.1% of all patients, respectively. p-4EBP1 overexpression was associated with advanced stage (p=0.04), histologic grade (pb0.01), residual mass (pb0.01), shorter disease-free survival rate (p=0.01) and chemoresistance (p=0.02). p-p70S6K was associated with residual mass with marginal significance (p=0.06). p-4EBP1 expression was correlated with p-p70S6K expression (r=0.42, pb0.01), whereas p-mTOR was not associated with expression of its downstream effectors or prognostic factors.
Conclusions. Our findings suggest that p-4EBP1 expression was associated with poor prognostic factors of ovarian cancer and that p-4EBP1 overexpression may be a prognostic biomarker of ovarian cancer.
ko_KR
dc.language.isoenko_KR
dc.publisherElsevierko_KR
dc.subjectp-mTORko_KR
dc.subjectp-4EBP1ko_KR
dc.subjectp-p70S6Kko_KR
dc.subjectEpithelial ovarian cancerko_KR
dc.titleActivation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancerko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor노재홍-
dc.contributor.AlternativeAuthor전용탁-
dc.contributor.AlternativeAuthor박인애-
dc.contributor.AlternativeAuthor김용범-
dc.contributor.AlternativeAuthor김재원-
dc.contributor.AlternativeAuthor박노현-
dc.contributor.AlternativeAuthor강순범-
dc.contributor.AlternativeAuthor한재용-
dc.contributor.AlternativeAuthor임정묵-
dc.contributor.AlternativeAuthor송용상-
dc.identifier.doi10.1016/j.ygyno.2010.12.364-
Appears in Collections:
College of Agriculture and Life Sciences (농업생명과학대학)Dept. of Food and Animal Biotechnology (식품·동물생명공학부)Journal Papers (저널논문_식품·동물생명공학부)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse